Skip to main content

View full-text article in PMC

. 2012 May 16;61(11):2135–2141. doi: 10.1007/s00262-012-1281-x

Table 2.

The distribution of HLA-DRB1*0901, 1501 and DQB1*0301, 0602 in HPV16 positive and HPV16 negative in control group (no cancer patients)

HLA	HPV16 positive		HPV16 negative
HLA	(n = 24)	AF	(n = 126)	AF	X²	P	OR (95 % CI)
DRB1*0901	3	0.125	11	0.087	0.339	0.561	1.494 (0.384–5.811)
DRB1*1501	7	0.292	31	0.246	0.222	0.638	1.262 (0.479–3.326)
DQB1*0301	11	0.458	62	0.492	0.092	0.762	0.873 (0.364–2.097)
DQB1*0602	15	0.548	69	0.625	0.490	0.484	1.377 (0.561–3.379)